Roles of Ceramides in Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease is one of the most common chronic liver diseases, ranging from simple steatosis to steatohepatitis, fibrosis, and cirrhosis. Its prevalence is rapidly increasing and presently affects around 25% of the general population of Western countries, due to the obesity epid...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine Vol. 10; no. 4; p. 792
Main Authors: Hajduch, Eric, Lachkar, Floriane, Ferré, Pascal, Foufelle, Fabienne
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 16.02.2021
MDPI
Subjects:
Adipocytes
Biosynthesis
Body fat
Cell growth
Clinical medicine
Diabetes
Enzymes
Fatty acids
Fatty liver
Food and Nutrition
Glucose
Inflammation
Insulin resistance
Life Sciences
Lipids
Liver cirrhosis
Liver diseases
Mammals
Obesity
Oxidation
Review
Roles
Signal transduction
NAFLD
ceramide
NASH
liver
sphingolipids
steatosis
ISSN:2077-0383, 2077-0383
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Non-alcoholic fatty liver disease is one of the most common chronic liver diseases, ranging from simple steatosis to steatohepatitis, fibrosis, and cirrhosis. Its prevalence is rapidly increasing and presently affects around 25% of the general population of Western countries, due to the obesity epidemic. Liver fat accumulation induces the synthesis of specific lipid species and particularly ceramides, a sphingolipid. In turn, ceramides have deleterious effects on hepatic metabolism, a phenomenon called lipotoxicity. We review here the evidence showing the role of ceramides in non-alcoholic fatty liver disease and the mechanisms underlying their effects.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm10040792